Yeast

Evolva will reduce the cost of its new yeast-derived resveratrol, it says

Evolva pays €550,000 for Fluxome resveratrol business

By Shane Starling

Swiss biotech firm Evolva has bought failing Fluxome’s, yeast-derived resveratrol business for about €550,000 in cash and shares, but says it has no interest in the remaining omega-3 business being sold by sealed auction.

BLIS K12 decreased the adherence of C. albicans to the petri dish

Probiotic BLIS K12 may protect against oral yeast growth

By Stephen Daniells

Supplements containing the probiotic BLIS K12 ingredient may inhibit the growth of the yeast responsible for oral thrush, suggests new in vitro data that supports the oral health potential of the ingredient.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers